MDA Space Ltd (TSX:MDA) (NYSE:MDA) saw its shares climb 3.3% in premarket trade Monday after unveiling a definitive agreement to acquire Blue Canyon Technologies LLC for US$620 million in an all-cash transaction.
The target, currently part of RTX’s Raytheon business, will be purchased in full. MDA said the acquisition is intended to broaden its total addressable market and better position the company to pursue opportunities within the U.S. defense market.
Blue Canyon Technologies brings more than 400 employees and operates two manufacturing facilities in Denver, Colorado. Since its founding in 2008, the company has launched over 85 spacecraft and has more than 3,500 products on orbit, according to MDA.
MDA noted the transaction will add US$3.5 billion to its opportunity pipeline. Management projects the deal will be accretive to Adjusted EBITDA and Adjusted EPS in 2027. The companies expect the transaction to close by the end of 2026, subject to customary closing conditions and regulatory approvals. Financing for the purchase will be provided through senior secured debt.
Analyst reactions and price target moves
- BMO Capital analyst Thanos Moschopoulos raised his price target to C$68.00 from C$53.00 and maintained an Outperform rating. BMO Capital commented:
"We remain Outperform on MDA and raise our target price to C$68 following the announcement of MDA’s US$620mm acquisition of Blue Canyon Technologies (BCT). In our view, the acquisition should significantly expand MDA’s TAM by opening the door to a far broader slate of U.S. government/defense opportunities."
- Canaccord analyst Doug Taylor lifted his price target to C$65.00 from C$56.00 and kept a Buy rating.
- Scotiabank analyst Konark Gupta inching up his target to C$71.00 from C$70.00 with a Sector Outperform rating.
The announced purchase combines MDA’s existing capabilities with Blue Canyon Technologies’ satellite manufacturing footprint and operational track record. Company statements emphasize the addition of workforce, facilities and on-orbit heritage as contributors to a larger addressable market and a deeper pipeline of potential business.
Key calendar items include the expected close by the end of 2026 and the company’s projection that the acquisition will be accretive to key adjusted profitability measures in 2027, both outcomes conditioned on customary closing steps and regulatory sign-offs.
Investors and market participants reacted to the deal and analyst updates with a modest premarket rise in MDA’s share price.